GLAUKOS CORP.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 907
- Market Cap
- $7.4B
- Website
- http://www.glaukos.com
Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
Phase 3
Withdrawn
- Conditions
- Corneal Ectasia
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Registration Number
- NCT01643252
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Phase 3
Completed
- Conditions
- Keratoconus
- Interventions
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT01643226
- Locations
- 🇺🇸
Durrie Vision, Overland Park, Kansas, United States
🇺🇸Columbia University Harkness Eye Institute, New York, New York, United States
🇺🇸Cornea & Laser Eye Institute; Hersh Vision Group, Teaneck, New Jersey, United States
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
Not Applicable
Completed
- Conditions
- Primary Open Angle Glaucoma (POAG)
- Interventions
- Device: iStent
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 119
- Registration Number
- NCT01517477
- Locations
- 🇦🇲
S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Not Applicable
Completed
- Conditions
- Primary Open-angle Glaucoma
- Interventions
- Procedure: Cataract surgeryDevice: iStent inject
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 505
- Registration Number
- NCT01461291
- Locations
- 🇺🇸
Eye Centers of Racine and Kenosha, Racine, Wisconsin, United States
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Not Applicable
Completed
- Conditions
- Primary Open-angle Glaucoma
- Interventions
- Procedure: Cataract surgeryDevice: iStent supra
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 505
- Registration Number
- NCT01461278
- Locations
- 🇺🇸
Eye Centers of Racine and Kenosha, Racine, Wisconsin, United States
Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
Not Applicable
Completed
- Conditions
- Open-Angle Glaucoma
- Interventions
- Device: iStent and iStent supra
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 79
- Registration Number
- NCT01456390
- Locations
- 🇦🇲
S.V. Malayan Ophthalmological Center, Yerevan, Armenia
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
Not Applicable
Completed
- Conditions
- Open-angle Glaucoma
- Interventions
- Device: Two iStentDevice: One iStent
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 79
- Registration Number
- NCT01455467
- Locations
- 🇦🇲
S.V. Malayan Ophthalmological Center, Yerevan, Armenia
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 196
- Registration Number
- NCT01444040
- Locations
- 🇦🇲
S.V. Malayan Ophthalmological Center, Yerevan, Armenia
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 101
- Registration Number
- NCT01443988
- Locations
- 🇦🇲
S.V. Malayan Ophthalmological Center, Yerevan, Armenia
Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
Not Applicable
Completed
- Conditions
- Open-angle Glaucoma
- Interventions
- Device: iStentOther: SLT
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT01444105
- Locations
- 🇦🇲
S.V. Malayan Ophthalmological Center, Yerevan, Armenia